Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Safety and Efficacy Study of AAV2-hAADC Administered by MRI-Guided Convective Infusion Using a Transfrontal Trajectory Into the Putamen and Caudate of Participants With Young Onset Parkinson's Disease

NCT07267065 is registered in ClinicalTrials.gov with Krzysztof Bankiewicz as lead sponsor.

NCT NCT07267065
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07267065 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Safety and Efficacy Study of AAV2-hAADC Administered by MRI-Guided Convective Infusion Using a Transfrontal Trajectory Into the Putamen and Caudate of Participants With Young Onset Parkinson's Disease
Lead sponsor
Krzysztof Bankiewicz
Phase
Phase 1
Overall status
Not yet recruiting
Start date
August 1, 2026
Completion date
December 1, 2028
Enrollment
9 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

early onset parkinson disease, parkinson's disease (pd)